SynthesisLancet (London, England)2022

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.